venerdì, 31 marzo 2023
12 Ottobre 2018

Expanded FDA Clearances Speed Scalp Cooling Acceptance in Oncology Community

October 11, 2018 – Scalp cooling to limit alopecia in patients with cancer who are receiving chemotherapy is edging closer to becoming a widespread patient offering following recent FDA clearances, according to a talk at the 2018 Lynn Sage Breast Cancer Symposium. “Scalp cooling is efficacious and has the potential to enhance quality of life and improve meaningful outcomes,” said Mikel Ross MSN, of the Department of Nursing – Breast Medicine Service at Memorial … (leggi tutto)